Renata PLC (DSE:RENATA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
480.90
-5.00 (-1.03%)
At close: Sep 22, 2025
-1.03%
Market Cap55.16B
Revenue (ttm)41.39B
Net Income (ttm)2.81B
Shares Out114.70M
EPS (ttm)24.53
PE Ratio19.61
Forward PE22.04
Dividend9.20 (1.89%)
Ex-Dividend DateOct 22, 2024
Volume25,029
Average Volume96,876
Open486.00
Previous Close485.90
Day's Range480.00 - 489.90
52-Week Range468.00 - 780.00
Beta-0.04
RSI38.05
Earnings DateOct 9, 2025

About Renata

Renata PLC manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, a... [Read more]

Industry Pharmaceutical Preparations
Founded 1972
Employees 7,859
Stock Exchange Dhaka Stock Exchange
Ticker Symbol RENATA
Full Company Profile

Financial Performance

In 2024, Renata's revenue was 37.71 billion, an increase of 14.37% compared to the previous year's 32.97 billion. Earnings were 3.62 billion, an increase of 54.57%.

Financial Statements

News

There is no news available yet.